Explore
National Library of Medicine

National Library of Medicine

Archive-It Partner Since: Mar, 2009

Organization Type: National Institutions

Organization URL: http://www.nlm.nih.gov/

Description:

The National Library of Medicine (NLM), the world's largest medical library and a component of the National Institutes of Health, collects, preserves, and makes available to the public information about health, medicine, and the biomedical sciences. To continue fulfilling this mission, NLM is collecting and archiving related Web content, which also serves to document the histories of health and medicine. For questions about our web archiving program contact us at nlmwebcollecting@nlm.nih.gov.

Sites and collections from this organization are listed below. Narrow your results at left, or enter a search query below to find a collection, site, specific URL or to search the text of archived webpages.

Page 1 of 1 (15 Total Results)

Sort By:

Title: An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission | Pfizer

URL: https://www.pfizer.com/news/press-release/press-release-detail/vitro-study-shows-pfizer-biontech-covid-19-vaccine-elicits

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Biomedical Research, Vaccines, Variants, Alpha, Beta, Tracking the Disease

Title: EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union | pfpfizeruscom

URL: https://www.pfizer.com/news/press-release/press-release-detail/ema-approves-new-storage-option-pfizer-biontech-vaccine

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Prevention and Control/Risk Management, Vaccines

Title: Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age | Pfizer

URL: https://www.pfizer.com/news/press-release/press-release-detail/follow-data-phase-3-trial-pfizer-biontech-covid-19-vaccine

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Biomedical Research, Vaccines, Vulnerable Populations, Children

Title: Pfizer Inc. - Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose

URL: https://investors.pfizer.com/Investors/News/news-details/2022/Pfizer-BioNTech-COVID-19-Vaccine-Demonstrates-Strong-Immune-Response-High-Efficacy-and-Favorable-Safety-in-Children-6-Months-to-Under-5-Years-of-Age-Following-Third-Dose/default.aspx

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Biomedical Research, Vaccines, Vulnerable Populations, Children

Title: Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants | Pfizer

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-initiates-phase-23-study-novel-covid-19-oral

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Vaccines, Biomedical Research

Title: Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study | Pfizer

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Vaccines, Biomedical Research

Title: Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints | Pfizer

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine/

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Biomedical Research, Vaccines

Title: Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age | Pfizer

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-initiate-study-evaluate-omicron-based

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Biomedical Research, Vaccines, Patient Treatment and Experience, Variants, Omicron

Title: Pfizer and BioNTech Provide Update on Ongoing Studies of COVID-19 Vaccine | Pfizer

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-update-ongoing-studies-covid-19

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Biomedical Research, Vaccines, Vulnerable Populations, Children

Title: Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture | pfpfizeruscom

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-puresults-study-showing-covid-19/

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Biomedical Research, Vaccines

Title: Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents | pfpfizeruscom

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-receive-first-us-authorization

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Prevention and Control/Risk Management, Vaccines

Title: Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations | pfpfizeruscom

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-500-million-doses-covid-19

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Prevention and Control/Risk Management, Vaccines

Title: Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games | pfpfizeruscom

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-covid-19-vaccine-doses-olympic

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Geographic Location: Japan

Collector: National Library of Medicine (U.S.)

Keyword: Prevention and Control/Risk Management, Vaccines, Social Dimensions

Title: Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents | pfpfizeruscom

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-biontech-announce-positive-topline-results-pivotal

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Biomedical Research, Vaccines

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-receive-positive-chmp-opinion-covid-19

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Pfizer Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Vaccines, Prevention and Control/Risk Management

Page 1 of 1 (15 Total Results)

Archive-It

The leading web archiving service for collecting and accessing cultural heritage on the web

National Library of Medicine

Narrow Your Results

Title: An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission | Pfizer

URL: https://www.pfizer.com/news/press-release/press-release-detail/vitro-study-shows-pfizer-biontech-covid-19-vaccine-elicits

Title: EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union | pfpfizeruscom

URL: https://www.pfizer.com/news/press-release/press-release-detail/ema-approves-new-storage-option-pfizer-biontech-vaccine

Title: Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age | Pfizer

URL: https://www.pfizer.com/news/press-release/press-release-detail/follow-data-phase-3-trial-pfizer-biontech-covid-19-vaccine

Title: Pfizer Inc. - Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose

URL: https://investors.pfizer.com/Investors/News/news-details/2022/Pfizer-BioNTech-COVID-19-Vaccine-Demonstrates-Strong-Immune-Response-High-Efficacy-and-Favorable-Safety-in-Children-6-Months-to-Under-5-Years-of-Age-Following-Third-Dose/default.aspx

Title: Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants | Pfizer

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-initiates-phase-23-study-novel-covid-19-oral

Title: Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study | Pfizer

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against

Title: Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints | Pfizer

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine/

Title: Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age | Pfizer

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-initiate-study-evaluate-omicron-based

Title: Pfizer and BioNTech Provide Update on Ongoing Studies of COVID-19 Vaccine | Pfizer

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-update-ongoing-studies-covid-19

Title: Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture | pfpfizeruscom

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-puresults-study-showing-covid-19/

Title: Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents | pfpfizeruscom

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-receive-first-us-authorization

Title: Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations | pfpfizeruscom

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-500-million-doses-covid-19

Title: Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games | pfpfizeruscom

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-covid-19-vaccine-doses-olympic

Title: Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents | pfpfizeruscom

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-biontech-announce-positive-topline-results-pivotal

URL: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-receive-positive-chmp-opinion-covid-19

Archive-It